NASDAQ:SRDX
SurModics Stock News
$32.16
-0.160 (-0.495%)
At Close: May 10, 2024
Recap: Surmodics Q3 Earnings
07:48am, Wednesday, 04'th Aug 2021
Shares of Surmodics (NASDAQ:SRDX) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell 180.95% year over year to ($0.17), which were in line with the es
Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
07:30am, Wednesday, 04'th Aug 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #IVD--Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
Surmodics Announces Successful First Patient Use of Pounce™ Thrombectomy System
08:30am, Thursday, 29'th Jul 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #510K--Surmodics Announces Successful First Patient Use of Pounce™ Thrombectomy System
HRC vs. SRDX: Which Stock Should Value Investors Buy Now?
12:59pm, Monday, 19'th Jul 2021
HRC vs. SRDX: Which Stock Is the Better Value Option?
Surmodics (SRDX) Boosts Portfolio With Vetex Medical Buyout
08:16am, Wednesday, 07'th Jul 2021
Surmodics' (SRDX) buyout of Vetex Medical adds second FDA 510 (k) cleared device to its thrombectomy platform.
Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited
08:05am, Tuesday, 06'th Jul 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #Acquisition--Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited
HRC vs. SRDX: Which Stock Is the Better Value Option?
12:47pm, Friday, 02'nd Jul 2021
HRC vs. SRDX: Which Stock Is the Better Value Option?
EYE or SRDX: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 19'th May 2021
EYE vs. SRDX: Which Stock Is the Better Value Option?
Surmodics (SRDX) Q2 Earnings Beat Estimates, Revenues Miss
02:17pm, Thursday, 29'th Apr 2021
Surmodics (SRDX) records higher revenues in both its core units in the fiscal second quarter.
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q2 2021 Results - Earnings Call Transcript
05:53pm, Wednesday, 28'th Apr 2021
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q2 2021 Results - Earnings Call Transcript
SurModics (SRDX) Beats Q2 Earnings Estimates
10:02am, Wednesday, 28'th Apr 2021
SurModics (SRDX) delivered earnings and revenue surprises of 3.33% and -0.07%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Surmodics Q2 Earnings
07:42am, Wednesday, 28'th Apr 2021
Shares of Surmodics (NASDAQ:SRDX) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 1450.00% over the past year to $0.62, which missed the estimate o
PAHC or SRDX: Which Is the Better Value Stock Right Now?
12:53pm, Wednesday, 07'th Apr 2021
PAHC vs. SRDX: Which Stock Is the Better Value Option?
Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021
09:51am, Thursday, 01'st Apr 2021
Let's take a look at the three MedTech stocks performing well lately, banking on a host of impressive developments.
Surmodics to Present at Sidoti & Company Virtual Investor Conference
04:05pm, Wednesday, 17'th Mar 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #SRDX--Surmodics to Present at Sidoti & Company Virtual Investor Conference Thursday, March 25, at 10:00 a.m. (ET)
